Back to Search
Start Over
FDA approves first biosimilar to Neulasta
- Source :
- The Fly. June 4, 2018
- Publication Year :
- 2018
-
Abstract
- The U.S. Food and Drug Administration today approved Fulphila, pegfilgrastim-jmdb, as the first biosimilar to Neulasta to decrease the chance of infection as suggested by febrile neutropeniafever, often with other [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.541347161